When a life-changing diagnosis brings moments of uneasiness, a glimmer of hope can make all the difference in bringing solace. As hope comes in many forms, Extended Stay America® hotels, the nation’s largest owner operated hotelier, announced today the launch of the brand’s latest initiative in their continued support for the fight against cancer – the “Give Hope” program. A natural evolution of Extended Stay America’s partnership with the American Cancer Society, the “Give Hope” program provides a platform to raise awareness and funds for pediatric cancer research.
To view the multimedia release go to:
https://www.multivu.com/players/English/8060751-extended-stay-america-give-hope-cancer-research/
Allergan plc (NYSE:AGN), a global leader in eye care for nearly 70 years, today unveiled #EyePic, an exciting new online awareness campaign as part of the See America initiative to fight preventable blindness and visual impairment in the United States. #EyePic will use the power of social media to broaden awareness of preventable blindness, promote discussion around eye health and ultimately encourage all Americans to visit their eye doctors for comprehensive eye exams.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134051-allergan-see-america-eyepic-campaign/
St. Jude Children’s Research Hospital is naming the institution’s principal research tower after Donald Pinkel, M.D., whose legacy of driving progress toward advancing cures for pediatric catastrophic diseases continues at the institution today.
When St. Jude was established 55 years ago, Pinkel, the hospital’s first medical director, committed to finding cures for childhood cancer, leading to groundbreaking treatments that saved countless children’s lives. Many of these cancers were deemed incurable prior to Pinkel’s research, but his distinct approach to eradicating diseases established a model for how cancers could be treated.
To view the multimedia release go to:
https://www.multivu.com/players/English/7924752-st-jude-childrens-research-hospital-donald-pinkel-tower/
HMR Weight Management Services Corp. (HMR), a subsidiary of Merck, held its position as a No. 1 “Best Fast Weight-Loss Diet” in the 2017 Best Diets rankings released today by U.S. News & World Report. It’s the second year in a row HMR earned the top spot in the category, which was added to the annual rankings list last year.
“HMR’s highly structured diet and lifestyle change program is designed to help people lose weight quickly while learning the skills they need to keep it off,” said Carol Addy, M.D. MMSc, Chief Medical Officer at HMR. “Fast weight loss without lifestyle change isn’t sustainable. HMR gets fast weight loss, but our true expertise is helping people learn realistic ways to incorporate new healthy behaviors into their everyday lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/8003751-hmr-best-fast-weight-loss-diet-2017/
Are You Suffering from hemorrhoids that don't want to go away? Hemorrhoids are unpleasant and worrisome. Getting rid of hemorrhoids can be difficult. And, you don’t want to strain when having a bowel movement, otherwise they will get bigger. But, do you know if you have hemorrhoids? Do you have some of these symptoms?
HealthCare Partners, a division of DaVita Inc. (NYSE: DVA), a leading independent medical group in the United States, is encouraging Medicare beneficiaries to review their health care coverage during Medicare’s Open Enrollment Period.
From October 15 through December 7, Medicare holds its annual Open Enrollment Period. During this seven-week window, Medicare beneficiaries can make changes to their health and prescription drug plans for the following year.
If you are satisfied with your Medicare coverage, you may wonder how open enrollment applies to you. As the old adage goes, “if it isn’t broke, don’t fix it,” right?
While this may certainly be the case for many things in life, it may not be true about your Medicare coverage. Choosing a Medicare plan is similar to shopping for other insurance; by comparing different plans and rates, you choose the coverage that’s best for you.
To view the multimedia release go to:
http://www.multivu.com/players/English/7920151-healthcare-partners-medicare-open-enrollment/
Living with type 1 diabetes comes with many unique challenges in all stages of life. For parents of children with the condition, financial, medical and emotional worries can be overwhelming. To help support people with diabetes and those who love them, Lilly Diabetes today announced it will donate $94,000 to the American Diabetes Association (Association) Campership program and $100,000 to the Diabetes Scholars Foundation (Foundation).
To view the multimedia release go to:
http://www.multivu.com/players/English/8004851-lilly-diabetes-scholarship-donations/
After fourteen years, more than $7 million raised and more than 900 wishes granted, Maggiano’s Little Italy® is proud to once again kick off its annual campaign benefiting Make-A-Wish®, a nonprofit organization that grants the wishes of children with life-threatening medical conditions. This year, Maggiano’s is tapping into Guests’ favorite weekly tradition, brunch, and inviting them to “Brunch With A Purpose,” where $1 will be donated to Make-A-Wish for every brunch entrée ordered.
To view the multimedia release go to:
https://www.multivu.com/players/English/8012052-maggianos-make-a-wish-campaign-eatadish4maw/
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients.
“The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
Outsource dermatology transcription to reliable medical transcription services for precise, efficient documentation and delivery of quality patient care.
